Trials / Completed
CompletedNCT00144248
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to evaluate the steady-state clearance of nevirapine among HIV-1 positive patients with hepatic fibrosis, and to examine whether the degree of hepatic impairment influences clearance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nevirapine |
Timeline
- Start date
- 2004-06-25
- Primary completion
- 2006-06-01
- First posted
- 2005-09-05
- Last updated
- 2023-12-01
Locations
8 sites across 3 countries: United States, France, Spain
Source: ClinicalTrials.gov record NCT00144248. Inclusion in this directory is not an endorsement.